Vivo Capital, LLC
Net seller this quarter
$1.1B
47
-$218M
52.4%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 TRVI | $95M | 8.68% | 3.58% | Not reported | Q3 2024 |
 PRAX | $90.8M | 8.29% | 0.97% | -20.0% | Q2 2025 |
 ERAS | $75.6M | 6.90% | 1.32% | -66.0% | Q2 2024 |
 AVBP | $58.4M | 5.34% | 3.48% | +89.9% | Q1 2026 |
 ABVX | $55.3M | 5.05% | 0.53% | +73.2% | Q3 2025 |
 TNGX | $43.1M | 3.94% | 0.82% | -36.0% | Q2 2025 |
 CRVS | $41.9M | 3.83% | 3.34% | Not reported | Q3 2024 |
 DRUG | $39.1M | 3.57% | 7.30% | Not reported | Q4 2024 |
| SVA | $38.2M | 3.49% | 8.21% | Not reported | Q3 2018 |
 TENX | $36.4M | 3.32% | 7.82% | +1100.0% | Q3 2024 |
 ACRS | $35.4M | 3.23% | 4.79% | +0.4% | Q1 2016 |
 DYN | $34.6M | 3.16% | 0.94% | Not reported | Q3 2020 |
 DNTH | $34.5M | 3.15% | 0.65% | Not reported | Q3 2025 |
 ANRO | $31.9M | 2.91% | 3.44% | +16.7% | Q4 2025 |
 DBVT | $30.3M | 2.76% | 0.62% | -30.8% | Q4 2018 |
 SABS | $28.5M | 2.60% | 8.74% | -36.1% | Q3 2025 |
 MLTX | $27.3M | 2.49% | 1.90% | +40.0% | Q4 2025 |
 LBRX | $26M | 2.37% | 2.79% | Not reported | Q3 2025 |
 NERV | $24M | 2.19% | 9.15% | Not reported | Q2 2016 |
 DSGN | $23.3M | 2.13% | 2.58% | Not reported | Q1 2021 |
 ORIC | $20M | 1.83% | 1.78% | Not reported | Q3 2023 |
 CAMP | $18.6M | 1.69% | 8.18% | Not reported | Q3 2025 |
 FTH | $18.1M | 1.65% | 2.80% | Not reported | Q1 2026 |
 ACHV | $18M | 1.64% | 2.68% | New | Q2 2026 |
 CMPX | $17M | 1.55% | 4.31% | -18.7% | Q4 2021 |
 ANTX | $15.3M | 1.39% | 8.69% | Not reported | Q1 2026 |
 EDIT | $11.5M | 1.05% | 3.63% | New | Q2 2026 |
 GERN | $11.1M | 1.01% | 1.35% | Not reported | Q1 2022 |
 ODTX | $10.8M | 0.98% | 1.20% | New | Q2 2026 |
 EPRX | $8.92M | 0.81% | 2.60% | Not reported | Q3 2025 |
 OKUR | $8.79M | 0.80% | 4.77% | Not reported | Q1 2026 |
 OLMA | $8.4M | 0.77% | 0.77% | Not reported | Q4 2020 |
 MNPR | $8.38M | 0.77% | 1.35% | Not reported | Q3 2025 |
 AURA | $8.28M | 0.76% | 1.13% | New | Q2 2026 |
 SRZN | $6.75M | 0.62% | 2.21% | Not reported | Q1 2025 |
 ALXO | $6.59M | 0.60% | 2.30% | Not reported | Q3 2020 |
 MSLE | $6.33M | 0.58% | 63.16% | Not reported | Q1 2026 |
 AVTX | $5.08M | 0.46% | 0.52% | New | Q2 2026 |
 PEPG | $4.19M | 0.38% | 3.36% | Not reported | Q3 2025 |
 VALN | $3.99M | 0.36% | 0.44% | Not reported | Q2 2021 |
 SERA | $3M | 0.27% | 5.63% | Not reported | Q3 2021 |
 UNCY | $2.58M | 0.24% | 1.97% | -69.3% | Q3 2023 |
 TIL | $2.25M | 0.21% | 4.32% | Not reported | Q1 2021 |
 INM | $1.24M | 0.11% | 14.95% | New | Q2 2026 |
 BOLT | $279K | 0.03% | 3.76% | Not reported | Q1 2021 |
 KTTA | $240K | 0.02% | 1.39% | -77.8% | Q4 2025 |
 DTIL | $36.7K | 0.00% | 0.02% | Not reported | Q1 2019 |
| Q1 2026 | |||||
| ERAS | $197M | 16.34% | 3.91% | +31.0% | Q2 2024 |
| PRAX | $109M | 9.08% | 1.22% | +3.0% | Q2 2025 |
| TERN | $70.4M | 5.85% | 1.16% | -75.0% | Q1 2021 |
| TRVI | $60.8M | 5.05% | 3.97% | Not reported | Q3 2024 |
| DBVT | $55.7M | 4.63% | 0.90% | +8.4% | Q4 2018 |
| CMPX | $50.5M | 4.20% | 5.30% | Not reported | Q4 2021 |
| TNGX | $45.1M | 3.75% | 1.49% | Not reported | Q2 2025 |
| SABS | $43.7M | 3.64% | 15.08% | Not reported | Q3 2025 |
| CRVS | $41M | 3.41% | 3.34% | +25.6% | Q3 2024 |
| DRUG | $40.7M | 3.38% | 7.30% | +11.1% | Q4 2024 |
| SVA | $38.2M | 3.17% | 8.21% | Not reported | Q3 2018 |
| DNTH | $29.7M | 2.47% | 0.65% | Not reported | Q3 2025 |
| DYN | $28.2M | 2.35% | 0.94% | -40.4% | Q3 2020 |
| ABVX | $26.7M | 2.22% | 0.31% | -33.3% | Q3 2025 |
| NERV | $26M | 2.17% | 9.86% | Not reported | Q2 2016 |
| ACRS | $25M | 2.08% | 4.77% | -25.0% | Q1 2016 |
| ORIC | $23.4M | 1.95% | 1.79% | -12.7% | Q3 2023 |
| ANRO | $23.3M | 1.94% | 2.95% | Not reported | Q4 2025 |
| FTH | $22.8M | 1.89% | 53.87% | New | Q1 2026 |
| AVBP | $20.4M | 1.70% | 1.96% | New | Q1 2026 |
| LBRX | $19.7M | 1.64% | 2.79% | Not reported | Q3 2025 |
 MANE | $18.9M | 1.57% | 0.80% | New | Q1 2026 |
| CAMP | $18.7M | 1.56% | 8.18% | Not reported | Q3 2025 |
| MLTX | $18.6M | 1.55% | 1.90% | Not reported | Q4 2025 |
| DSGN | $17.2M | 1.43% | 2.58% | Not reported | Q1 2021 |
 COGT | $16.3M | 1.35% | 0.25% | -82.4% | Q3 2021 |
| GERN | $12.9M | 1.07% | 1.35% | -68.2% | Q1 2022 |
| UNCY | $11.8M | 0.98% | 7.09% | Not reported | Q3 2023 |
| ANTX | $10.8M | 0.90% | 8.76% | New | Q1 2026 |
| OLMA | $10M | 0.83% | 0.77% | Not reported | Q4 2020 |
| SLNO | $9.87M | 0.82% | 0.57% | -67.1% | Q3 2017 |
| EPRX | $9.77M | 0.81% | 2.60% | Not reported | Q3 2025 |
| OKUR | $7.98M | 0.66% | 14.10% | New | Q1 2026 |
| SRZN | $7.57M | 0.63% | 2.26% | Not reported | Q1 2025 |
| ALXO | $6.39M | 0.53% | 2.30% | Not reported | Q3 2020 |
| MNPR | $4.96M | 0.41% | 1.35% | Not reported | Q3 2025 |
| MSLE | $4.58M | 0.38% | 63.16% | New | Q1 2026 |
| PEPG | $4.12M | 0.34% | 3.36% | Not reported | Q3 2025 |
| SERA | $3.35M | 0.28% | 5.63% | Not reported | Q3 2021 |
| TENX | $3.33M | 0.28% | 0.86% | Not reported | Q3 2024 |
 VRDN | $3.25M | 0.27% | 0.16% | -83.1% | Q3 2021 |
| TIL | $2.41M | 0.20% | 4.32% | Not reported | Q1 2021 |
| KTTA | $1.56M | 0.13% | 8.42% | Not reported | Q4 2025 |
 CMPS | $1.11M | 0.09% | 0.15% | Not reported | Q3 2023 |
| BOLT | $293K | 0.02% | 3.77% | Not reported | Q1 2021 |
| DTIL | $25.7K | 0.00% | 0.02% | Not reported | Q1 2019 |
| Q4 2025 | |||||
| TERN | $216M | 13.96% | 4.76% | -22.5% | Q1 2021 |
| CDTX | $211M | 13.66% | 3.04% | -27.1% | Q4 2024 |
| PRAX | $96.9M | 6.27% | 1.31% | +65.4% | Q2 2025 |
| COGT | $85.2M | 5.51% | 1.49% | -14.0% | Q3 2021 |
| TRVI | $63.8M | 4.12% | 3.97% | Not reported | Q3 2024 |
| AVDL | $57.8M | 3.74% | 2.75% | Not reported | Q1 2020 |
| CMPX | $51.3M | 3.31% | 5.35% | Not reported | Q4 2021 |
| DYN | $51.1M | 3.31% | 1.59% | Not reported | Q3 2020 |
| ABVX | $48.5M | 3.13% | 0.46% | Not reported | Q3 2025 |
| DBVT | $47.2M | 3.05% | 1.46% | +133.4% | Q4 2018 |
| SABS | $42.7M | 2.76% | 23.99% | Not reported | Q3 2025 |
| SLNO | $41.4M | 2.68% | 1.71% | -60.7% | Q3 2017 |
| DRUG | $39.1M | 2.53% | 6.57% | Not reported | Q4 2024 |
| SVA | $38.2M | 2.47% | 8.21% | Not reported | Q3 2018 |
| GERN | $35.9M | 2.32% | 4.25% | Not reported | Q1 2022 |
| ERAS | $34.5M | 2.23% | 3.26% | Not reported | Q2 2024 |
 ZBIO | $31M | 2.00% | 1.57% | -27.9% | Q3 2024 |
| VRDN | $30.6M | 1.98% | 0.97% | Not reported | Q3 2021 |
| ACRS | $26.8M | 1.73% | 7.38% | Not reported | Q1 2016 |
| CAMP | $26M | 1.68% | 8.18% | +8.3% | Q3 2025 |
| TNGX | $19.1M | 1.23% | 1.59% | +177.4% | Q2 2025 |
| ANRO | $18.4M | 1.19% | 3.24% | New | Q4 2025 |
| LBRX | $17.8M | 1.15% | 3.16% | Not reported | Q3 2025 |
| NERV | $17.4M | 1.12% | 9.99% | Not reported | Q2 2016 |
| ORIC | $17.3M | 1.12% | 2.15% | -32.3% | Q3 2023 |
| CRVS | $17.2M | 1.11% | 2.99% | Not reported | Q3 2024 |
| OLMA | $16.8M | 1.09% | 0.83% | -55.4% | Q4 2020 |
| PEPG | $15.1M | 0.98% | 3.38% | Not reported | Q3 2025 |
| DSGN | $15.1M | 0.98% | 2.67% | Not reported | Q1 2021 |
| DNTH | $14.6M | 0.94% | 0.82% | Not reported | Q3 2025 |
| MLTX | $13.2M | 0.85% | 1.90% | New | Q4 2025 |
 CTMX | $12.3M | 0.79% | 1.70% | Not reported | Q2 2025 |
| UNCY | $10.3M | 0.67% | 8.09% | Not reported | Q3 2023 |
| EPRX | $10.2M | 0.66% | 2.60% | Not reported | Q3 2025 |
 ABEO | $9.71M | 0.63% | 3.35% | Not reported | Q2 2024 |
 VSTM | $8.54M | 0.55% | 1.42% | -58.2% | Q1 2020 |
 SLN | $6.72M | 0.43% | 0.78% | Not reported | Q4 2023 |
| MNPR | $5.91M | 0.38% | 1.35% | Not reported | Q3 2025 |
| SRZN | $5.88M | 0.38% | 2.66% | Not reported | Q1 2025 |
 PALI | $5.39M | 0.35% | 1.44% | New | Q4 2025 |
| SERA | $4.87M | 0.31% | 5.63% | Not reported | Q3 2021 |
| TIL | $3.22M | 0.21% | 4.32% | Not reported | Q1 2021 |
| KTTA | $2.71M | 0.18% | 9.09% | New | Q4 2025 |
| TENX | $2.54M | 0.16% | 2.24% | Not reported | Q3 2024 |
 ENGNW | $844K | 0.05% | Not reported | New | Q4 2025 |
| BOLT | $396K | 0.03% | 3.77% | -58.9% | Q1 2021 |
| DTIL | $19.4K | 0.00% | 0.02% | Not reported | Q1 2019 |
| Q3 2025 | |||||
| SLNO | $154M | 12.39% | 4.24% | -42.4% | Q3 2017 |
| VRNA | $149M | 11.97% | 0.20% | Not reported | Q2 2017 |
| CDTX | $126M | 10.11% | 4.47% | Not reported | Q4 2024 |
| TERN | $51.8M | 4.17% | 7.88% | Not reported | Q1 2021 |
| TRVI | $46.6M | 3.75% | 3.97% | +13.5% | Q3 2024 |
| AVDL | $41M | 3.30% | 2.76% | Not reported | Q1 2020 |
| COGT | $40.1M | 3.22% | 1.99% | +148.5% | Q3 2021 |
| SVA | $38.2M | 3.07% | 8.21% | Not reported | Q3 2018 |
| ORIC | $37.5M | 3.02% | 3.21% | Not reported | Q3 2023 |
| GERN | $37.3M | 3.00% | 4.27% | Not reported | Q1 2022 |
| CMPX | $33.4M | 2.69% | 5.38% | +58.0% | Q4 2021 |
| DYN | $33.1M | 2.66% | 1.83% | +134.5% | Q3 2020 |
| ABVX | $30.5M | 2.45% | 0.57% | New | Q3 2025 |
| DRUG | $30.4M | 2.45% | 6.57% | +99.4% | Q4 2024 |
| TRML | $28.3M | 2.28% | 2.30% | Not reported | Q4 2023 |
| ZBIO | $26.3M | 2.11% | 2.80% | Not reported | Q3 2024 |
| VSTM | $23.4M | 1.88% | 3.96% | +71.9% | Q1 2020 |
| SABS | $23M | 1.85% | 24.05% | New | Q3 2025 |
| VRDN | $21.2M | 1.71% | 1.19% | Not reported | Q3 2021 |
| AKRO | $20.6M | 1.66% | 0.54% | Not reported | Q1 2020 |
| ERAS | $20.2M | 1.63% | 3.27% | +37.3% | Q2 2024 |
 RZLT | $19.9M | 1.60% | 2.32% | Not reported | Q2 2022 |
| ACRS | $16.9M | 1.36% | 8.20% | Not reported | Q1 2016 |
| CRVS | $16.5M | 1.33% | 2.99% | Not reported | Q3 2024 |
| OLMA | $14.7M | 1.19% | 2.19% | Not reported | Q4 2020 |
| DNTH | $13.9M | 1.12% | 0.83% | New | Q3 2025 |
| LBRX | $12.6M | 1.02% | 3.16% | New | Q3 2025 |
| CAMP | $11.8M | 0.95% | 8.37% | New | Q3 2025 |
| ATXS | $11.3M | 0.91% | 2.75% | Not reported | Q3 2022 |
| PEPG | $10.7M | 0.86% | 7.09% | New | Q3 2025 |
| DBVT | $10.5M | 0.85% | 0.77% | Not reported | Q4 2018 |
| PRAX | $10.5M | 0.85% | 0.94% | +18.7% | Q2 2025 |
| ABEO | $9.73M | 0.78% | 3.52% | Not reported | Q2 2024 |
| CTMX | $9.2M | 0.74% | 1.75% | -50.0% | Q2 2025 |
| EPRX | $7.97M | 0.64% | 3.79% | New | Q3 2025 |
| UNCY | $7.8M | 0.63% | 8.58% | +57.4% | Q3 2023 |
| MNPR | $7.39M | 0.59% | 1.36% | New | Q3 2025 |
| TNGX | $6.52M | 0.53% | 0.70% | +29.5% | Q2 2025 |
 DCTH | $6.12M | 0.49% | 1.61% | Not reported | Q2 2023 |
| SLN | $5.74M | 0.46% | 0.78% | Not reported | Q4 2023 |
| ETNB | $5.54M | 0.45% | 0.25% | Not reported | Q3 2020 |
| TIL | $5.23M | 0.42% | 4.32% | Not reported | Q1 2021 |
| SERA | $5.05M | 0.41% | 5.63% | Not reported | Q3 2021 |
| SRZN | $3.35M | 0.27% | 3.03% | Not reported | Q1 2025 |
| TENX | $1.59M | 0.13% | 3.53% | Not reported | Q3 2024 |
| BOLT | $937K | 0.08% | 9.17% | Not reported | Q1 2021 |
| DTIL | $25.8K | 0.00% | 0.04% | Not reported | Q1 2019 |